Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors

PURPOSE: Thyroid alterations including de novo appearance of thyroid autoimmunity are adverse effects of tyrosine kinase inhibitors, used in solid and hematologic cancer therapy, but the relationship between thyroid alterations during this treatment and the outcome of chronic myeloid leukemia remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodia, R., Pani, F., Caocci, G., La Nasa, G., Simula, M. P., Mulas, O., Velluzzi, F., Loviselli, A., Mariotti, S., Boi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783879/
https://www.ncbi.nlm.nih.gov/pubmed/34283388
http://dx.doi.org/10.1007/s40618-021-01613-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783879/
https://www.ncbi.nlm.nih.gov/pubmed/34283388
http://dx.doi.org/10.1007/s40618-021-01613-5

Ejemplares similares